MORE►
beth shapiro
Dallas-based Colossal Biosciences introduced an AI platform it is using in its efforts to revive the extinct dodo. [Image: Colossal Biosciences]
Dallas’ Colossal Biosciences Unveils AI Platform to Help Revive the Dodo Bird
by Sandra Engelland | Oct 14, 2026
The Dallas-based de-extinction company said its GenoMorph platform continues a series of breakthroughs aimed at reviving extinct and endangered species.
by Quincy Preston |
Apr 30, 2026
At a $10 billion valuation—and spinning out new ventures—Colossal names the bluebuck its sixth de-extinction target, extending its biotech platform into antelope conservation through a global BioVault effort.
MORE►
by Quincy Preston |
Nov 4, 2025
The de-extinction startup is adding more than two decades of commercial cloning expertise to its portfolio with its first acquisition.
Days before the announcement, CEO Ben Lamm laid out his playbook at Venture Dallas 2025: run toward critics, treat promises to middle-America classrooms as seriously as commitments to investors—and spin out businesses worth more than $100 million.
MORE►
by David Seeley |
Sep 17, 2025
Dallas-based Colossal Biosciences announced an add-on Series C raise that values it at $10.32 billion. Meanwhile, eggs are being laid in Texas to help advance the "de-extinction" of the famously extinct dodo bird—with a little help from the Nicobar pigeon, the dodo's closest living relative.
MORE►
Ben Lamm with a pup Colossal calls a “de-extincted” dire wolf. Critics have challenged the label, but Lamm calls it “a semantic question, not a scientific one.” [Photo: Colossal Biosciences]
The Last Word: Colossal Biosciences’ Ben Lamm on Science, Skeptics, and the Sound of a Howl
by Quincy Preston | Jun 5, 2025
In one of his first deep interviews since Colossal's dire wolf debut made global noise, Ben Lamm joins the TechStuff podcast to talk mammoths, backlash, and why he's not here to play it safe.
MORE►
by Quincy Preston |
Apr 7, 2025
“Game of Thrones” made them famous, but the prehistoric dire wolves were real—and, according to Colossal Biosciences, have now returned after 12,500 years in what it calls the world’s first successful de-extinction. The work goes beyond headlines: It could change how we save endangered species.
Meet Romulus, Remus, and Khaleesi in a video—and hear dire wolf howls for the first time in more than 12 millennia.
MORE►
by Quincy Preston |
Jan 15, 2025
Best known for its moonshot mission to revive the woolly mammoth, Colossal Biosciences has secured $200 million in Series C funding led by TWG Global. The world's first de-extinction company, founded in 2021 by entrepreneur Ben Lamm and renowned Harvard geneticist George Church, Colossal Biosciences is working to restore Earth's lost biodiversity, "making science fiction into science fact."
MORE►
by Lance Murray |
Nov 21, 2024
“As bird species disappear, we lose key components of ecosystems, including pollinators, insectivores, and spreaders of seeds, with negative impacts for both human and planetary health," said Colossal co-founder and CEO Ben Lamm.
MORE►
